[CME: Mepolizumab, an Additional Therapeutic Agent for Severe Asthma]
about
[CME: Mepolizumab, an Additional Therapeutic Agent for Severe Asthma]
description
scientific article published on 01 January 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
[CME: Mepolizumab, an Additional Therapeutic Agent for Severe Asthma]
@en
type
label
[CME: Mepolizumab, an Additional Therapeutic Agent for Severe Asthma]
@en
prefLabel
[CME: Mepolizumab, an Additional Therapeutic Agent for Severe Asthma]
@en
P2093
P356
P1433
P1476
[CME: Mepolizumab, an Additional Therapeutic Agent for Severe Asthma]
@en
P2093
Sigrid Platzer
Thomas Fehr
Tsogyal Latshang
P304
P356
10.1024/1661-8157/A003076
P577
2018-01-01T00:00:00Z